{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:05:14Z","timestamp":1793840714120,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021824","name":"Government of Saskatchewan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008921","name":"Ministry of Agriculture - Saskatchewan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VS1-175531"],"award-info":[{"award-number":["VS1-175531"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PEE-183995"],"award-info":[{"award-number":["PEE-183995"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT \\u2013 153319"],"award-info":[{"award-number":["PJT \\u2013 153319"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.vaccine.2024.05.028","type":"journal-article","created":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T06:51:57Z","timestamp":1716101517000},"page":"125980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5161-8300","authenticated-orcid":false,"given":"Ravendra","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-7172","authenticated-orcid":false,"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Van Kessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akarin","family":"Asavajaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Uhlemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Joessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5188-131X","authenticated-orcid":false,"given":"Glenn","family":"Hamonic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3819-2074","authenticated-orcid":false,"given":"Zahed","family":"Khatooni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kroeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyne","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5307-5717","authenticated-orcid":false,"given":"Erin","family":"Scruten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Deck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Prysliak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Nickol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko","family":"Apel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Courant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson A.","family":"Kelvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Van Kessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9304-3813","authenticated-orcid":false,"given":"Nicolas","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8229-1611","authenticated-orcid":false,"given":"Volker","family":"Gerdts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"K\u00f6ster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"Falzarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6370-8661","authenticated-orcid":false,"given":"Trina","family":"Racine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2821-8357","authenticated-orcid":false,"given":"Arinjay","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.05.028_b0005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.vaccine.2024.05.028_b0010","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","article-title":"A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity","volume":"586","author":"Yang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.05.028_b0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.028_b0020","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.028_b0025","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.028_b0030","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.028_b0035","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.028_b0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41392-022-01039-2","article-title":"Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants","volume":"7","author":"Sun","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.vaccine.2024.05.028_b0045","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12985-021-01633-w","article-title":"Evolutionary trajectory of SARS-CoV-2 and emerging variants","volume":"18","author":"Singh","year":"2021","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2024.05.028_b0050","first-page":"e2140906","article-title":"Analysis of vaccine effectiveness against COVID-19 and the emergence of delta and other variants of concern in Utah","volume":"4","author":"Keegan","year":"2021","journal-title":"J Am Med AssocNetw Open"},{"key":"10.1016\/j.vaccine.2024.05.028_b0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41564-021-01053-0","article-title":"Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario","volume":"7","author":"Nasreen","year":"2022","journal-title":"Nat Microbiol"},{"issue":"422\u201332","key":"10.1016\/j.vaccine.2024.05.028_b0060","first-page":"e3","article-title":"Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants","volume":"3","author":"Banerjee","year":"2022","journal-title":"Med (N Y)"},{"key":"10.1016\/j.vaccine.2024.05.028_b0065","unstructured":"WHO. COVID-19 vaccine tracker and landscape. In: WHO, editor. COVID-19 vaccine tracker and landscape: WHO; 2022."},{"key":"10.1016\/j.vaccine.2024.05.028_b0070","article-title":"Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent booster","author":"Davis-Gardner","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.028_b0075","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204256119","article-title":"The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2","volume":"119","author":"Xiong","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2024.05.028_b0080","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2205784119","article-title":"A broad and potent neutralization epitope in SARS-related coronaviruses","volume":"119","author":"Yuan","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2024.05.028_b0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"Starr","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.05.028_b0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMp2118468","article-title":"Universal coronavirus vaccines - an urgent need","volume":"386","author":"Morens","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.028_b0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41541-022-00571-0","article-title":"A potent, broadly protective vaccine against SARS-CoV-2 variants of concern","volume":"7","author":"Wang","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2024.05.028_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104341","article-title":"Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses","volume":"86","author":"Halfmann","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2024.05.028_b0105","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq0839","article-title":"Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models","volume":"377","author":"Cohen","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.05.028_b0110","article-title":"Neutralizing antibodies against the SARS-CoV-2 omicron variant (BA.1) 1 to 18 weeks after the second and third doses of the BNT162b2 mRNA vaccine","volume":"5","author":"Lassauni\u00e8re","year":"2022","journal-title":"J Am Med AssocNetw Open"},{"key":"10.1016\/j.vaccine.2024.05.028_b0115","article-title":"Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants","volume":"3","author":"Banerjee","year":"2022","journal-title":"Med (N Y)"},{"key":"10.1016\/j.vaccine.2024.05.028_b0120","article-title":"Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during omicron BA.4 and BA.5 sublineage periods","volume":"6","author":"Link-Gelles","year":"2023","journal-title":"J Am Med AssocNetw Open"},{"key":"10.1016\/j.vaccine.2024.05.028_b0125","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.vaccine.2012.07.074","article-title":"Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia","volume":"31","author":"Ventura","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.028_b0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41541-021-00418-0","article-title":"\u201cWorld in motion\u201d \u2013 emulsion adjuvants rising to meet the pandemic challenges","volume":"6","author":"O\u2019Hagan","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2024.05.028_b0135","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.vaccine.2012.12.076","article-title":"Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains","volume":"31","author":"Westdijk","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.028_b0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41541-020-0187-4","article-title":"H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets","volume":"5","author":"de Jonge","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2024.05.028_b0145","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.vaccine.2023.03.035","article-title":"Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE\u2122","volume":"41","author":"Xu","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.028_b0150","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/v15020346","article-title":"Neutralizing efficacy of encapsulin nanoparticles against SARS-CoV2 variants of concern","volume":"15","author":"Khaleeq","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.05.028_b0155","doi-asserted-by":"crossref","first-page":"e0024322","DOI":"10.1128\/msphere.00243-22","article-title":"RBD-VLP vaccines adjuvanted with alum or SWE protect K18-hACE2 mice against SARS-CoV-2 VOC challenge","volume":"7","author":"Wong","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.vaccine.2024.05.028_b0160","doi-asserted-by":"crossref","first-page":"e1009705","DOI":"10.1371\/journal.ppat.1009705","article-title":"SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney","volume":"17","author":"Francis","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2024.05.028_b0165","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","article-title":"Highly accurate protein structure prediction for the human proteome","volume":"596","author":"Tunyasuvunakool","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.05.028_b0170","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"ProteinSci"},{"key":"10.1016\/j.vaccine.2024.05.028_b0175","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.bpj.2011.10.024","article-title":"Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization","volume":"101","author":"Xu","year":"2011","journal-title":"Biophys J"},{"key":"10.1016\/j.vaccine.2024.05.028_b0180","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2024.05.028_b0185","article-title":"Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective","volume":"30","author":"Guex","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.vaccine.2024.05.028_b0190","doi-asserted-by":"crossref","unstructured":"Garg R, Latimer L, Gerdts V, Potter A, van Drunen Littel-van den Hurk S. Vaccination with the RSV fusion protein formulated with a combination adjuvant induces long-lasting protective immunity. J Gen Virol. 2014;95:1043-54.","DOI":"10.1099\/vir.0.062570-0"},{"key":"10.1016\/j.vaccine.2024.05.028_b0195","first-page":"227","article-title":"The method of right and wrong cases (Constant Stimuli) without Gauss's formulae","volume":"2","author":"Spearman","year":"1908","journal-title":"Br J Psychol"},{"key":"10.1016\/j.vaccine.2024.05.028_b0200","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.05.028_b0205","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00194-21","article-title":"Cryo-EM structure of S-Trimer, a subunit vaccine candidate for COVID-19","volume":"95","author":"Ma","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.05.028_b0210","doi-asserted-by":"crossref","unstructured":"Ma J, Su D, Sun Y, Huang X, Liang Y, Fang L, et al. Cryo-EM structure of S-Trimer, a subunit vaccine candidate for COVID-19. LID - .00194-21 [pii] LID - 10.1128\/JVI.00194-21 [doi] LID - e00194-21. J Virol. 2021.","DOI":"10.1101\/2020.09.21.306357"},{"key":"10.1016\/j.vaccine.2024.05.028_b0215","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.abm5835","article-title":"SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies","volume":"375","author":"Reincke","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.05.028_b0220","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jbiotec.2012.06.038","article-title":"Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells","volume":"161","author":"Croset","year":"2012","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2024.05.028_b0225","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.abn8939","article-title":"Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters","volume":"377","author":"Yuan","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.05.028_b0230","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","article-title":"SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway","volume":"7","author":"Willett","year":"2022","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2024.05.028_b0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1473-3099(22)00816-7","article-title":"Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB","volume":"23","author":"Uraki","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.028_b0240","first-page":"9","article-title":"Challenges of storage and stability of mRNA-based COVID-19 vaccines","author":"Uddin","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.05.028_b0245","doi-asserted-by":"crossref","first-page":"e1010802","DOI":"10.1371\/journal.ppat.1010802","article-title":"Infectious viral shedding of SARS-CoV-2 Delta following vaccination: a longitudinal cohort study","volume":"18","author":"Garcia-Knight","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2024.05.028_b0250","article-title":"Transmission and infectious SARS-CoV-2 shedding kinetics in vaccinated and unvaccinated individuals","volume":"5","author":"Jung","year":"2022","journal-title":"J Am Med AssocNetw Open"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24005863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:45:55Z","timestamp":1778737555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24005863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":50,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0264410X24005863"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"125980"}}